3 Biomarker driven, adaptive treatment strategies for high risk paediatric tumors
Biomarker driven, adaptive treatment strategies for high risk paediatric tumors Jaroslav Štěrba, Professor of Oncology and Pediatrics, Masaryk University Regina Demlová, Director of CREATIC CoE, Head of Network Committee ECRIN-ERIC at #ICTD2026
▶︎
2 Keynote: Key cross-cutting challenges in ATMP clinical trials
▶︎
POCT in GM: Sarah Rickard & Dwaipayan Sen
▶︎
9 Regulators and HTA Bodies as co‑designers of clinical trials: aligning evidence generation
▶︎
The French Do Not Care About Work
▶︎
Access to Surgery and Medical Tourism
▶︎
Which country has the best education in the world? - The Global Story podcast, BBC World Service
▶︎
What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
▶︎
12 How AIFP works to deliver safer, more effective treatments for patients
▶︎
How Proctor’s texts in Karen Read lawsuit could free dangerous criminals
▶︎
ADD/ADHD | What Is Attention Deficit Hyperactivity Disorder?
▶︎
Aligning Kidney Care with the European Green Deal: Policy and Practice | CSH Kidney Care Susnet
▶︎
Doctor Explains Why They're Terrified to Speak Out
▶︎
11 Bizarre Symptoms of Vitamin D Deficiency (You NEED to Know)
▶︎
9 Newly Discovered Signs of ADHD
▶︎
Golden Retriever Meets Completely Broken Rescue for the First Time
▶︎
16 Framework to Prioritise Rare Diseases for ATMP Development
▶︎
But what is quantum computing? (Grover's Algorithm)
▶︎
Blindness Isn’t the Hard Part — Society Is (Molly Burke)
▶︎
5 Things That Surprise People Most About Hip Replacement
▶︎